Modification of Outcomes With Aspirin or Apixaban in Relation to CHADS 2 and CHA 2 DS 2 -VASc Scores in Patients With Atrial Fibrillation-Reference-Cited by-同舟云学术

Modification of Outcomes With Aspirin or Apixaban in Relation to CHADS 2 and CHA 2 DS 2 -VASc Scores in Patients With Atrial Fibrillation

Published:2013-02 Issue:1 Volume:6 Page:31-38
ISSN:1941-3149
Container-title:Circulation: Arrhythmia and Electrophysiology
language:en
Short-container-title:Circ Arrhythm Electrophysiol

Author:

Lip Gregory Y.H.¹,Connolly Stuart¹,Yusuf Salim¹,Shestakovska Olga¹,Flaker Greg¹,Hart Robert¹,Lanas Fernando¹,Xavier Denis¹,Eikelboom John¹

Affiliation:

1. From the University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK (G.Y.H.L.); Population Health Research Institute, McMaster University, Hamilton, Canada (S.C., S.Y., O.S., R.H., J.E.); University of Missouri, Columbia, MO (G.F.); Universidad de La Frontera, Temuco, Chile (F.L.); and Department of Pharmacology, St. John’s Medical College, Bangalore, India (D.X.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at ‘moderate risk’ [CHADS2 score=1]: Simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice

2. A 12-Year Follow-up Study of Patients With Newly Diagnosed Lone Atrial Fibrillation

3. Validation of Clinical Classification Schemes for Predicting Stroke

4. The CHADS2 score for stroke risk stratification in atrial fibrillation – friend or foe?

5. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: A nationwide cohort study

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Device‐Detected Atrial Fibrillation and the Impact of Prior Stroke in Stroke Prevention;Journal of the American Heart Association;2024-09-03

2. Toward More Personalized Management of Device-Detected Atrial Fibrillation;JAMA Neurology;2024-06-01

3. Nonprocedural bleeding after left atrial appendage closure versus direct oral anticoagulants: A subanalysis of the randomized PRAGUE‐17 trial;Journal of Cardiovascular Electrophysiology;2023-08-02

4. Antiplatelet agents for chronic kidney disease;Cochrane Database of Systematic Reviews;2022-02-28

5. The 2020 CCS atrial fibrillation guidelines for pharmacists: Top 10 takeaways;Canadian Pharmacists Journal / Revue des Pharmaciens du Canada;2021-11-17